Eudaimonia Partners, LLC Moderna, Inc. Transaction History

Eudaimonia Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $549,974 - $1.02 Million	-4,349 Closed	0 $0
Q3 2021 Oct 25, 2021	BUY	$221.9 - $484.47 $11,316 - $24,707	51 Added 1.19%	4,349 $1.67 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $81,713 - $147,802	629 Added 17.14%	4,298 $1.01 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $251,332 - $428,125	2,302 Added 168.4%	3,669 $480,000
Q4 2020 Feb 18, 2021	BUY	$65.74 - $169.86 $43,980 - $113,636	669 Added 95.85%	1,367 $143,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $37,929 - $66,205	698 New	698 $49,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.